FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1463-1466 November 11, 1993 Number 20 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Neonates with severe thrombocytopenia can have bleeding leading to death or lifelong residual defects. The predictors, frequency, and consequences of fetal thrombocytopenia are not known, nor is it known if there are maternal clinical features that could predict fetal thrombocytopenia.

Methods We conducted a seven-year cross-sectional study in which platelet counts were determined in newborns' umbilical-cord blood and blood obtained from their mothers at consecutive deliveries in one obstetrical unit. The relations of the umbilical-cord platelet count to maternal risk factors were determined.

Results Platelet counts were determined in blood samples from 15,471 mothers and 15,932 newborn infants. The cord-blood platelet count was less than 50,000 per cubic millimeter in 19 infants (0.12 percent; 95 percent confidence interval, 0.07 to 0.19 percent), whereas the platelet count was less than 150,000 per cubic millimeter in 6.6 percent of the mothers (95 percent confidence interval, 6.2 to 7.0 percent). One infant among those born to 756 mothers with incidental thrombocytopenia, 5 infants among those born to 1414 mothers with hypertension, and 4 infants among those born to 46 mothers with idiopathic thrombocytopenic purpura had cord-blood platelet counts between 20,000 and 50,000 per cubic millimeter. Only 6 infants (0.04 percent; 95 percent confidence interval, 0.01 to 0.08 percent) had cord-blood platelet counts of less than 20,000 per cubic millimeter; all their mothers were among the 18 whose 19 fetuses were at risk for neonatal alloimmune thrombocytopenia. Two of these infants had in utero intracranial hemorrhage. In addition, 3 infants born to these 18 women had cord-blood platelet counts between 20,000 and 50,000 per cubic millimeter; there was 1 stillbirth due to intracranial hemorrhage.

Conclusions Moderate-to-severe fetal thrombocytopenia is a rare event. The only severely affected neonates with morbidity or mortality due to this condition are those born to mothers with antiplatelet alloantibodies.

Source Information

From the Departments of Obstetrics and Gynecology, Medicine, and Pathology, McMaster University Medical Centre, and the Canadian Red Cross Blood Transfusion Service Hamilton Centre, Hamilton, Ont.

Address reprint requests to Dr. Burrows at the Department of Obstetrics and Gynecology, McMaster University Medical Centre, 1200 Main St. W., Hamilton, ON L8N 3Z5, Canada.

Full Text of this Article

Related Letters:

Fetal and Maternal Thrombocytopenia
Fischer J., Dietl J., Goelz R., Burrows R. F., Kelton J. G.
Extract | Full Text  
N Engl J Med 1994; 330:940-941, Mar 31, 1994. Correspondence

This article has been cited by other articles:

• Myers, B. (2009). Thrombocytopenia in pregnancy. The Obstetrician and Gynaecologist 11: 177-183 [Abstract] [Full Text]  
• Kjeldsen-Kragh, J., Killie, M. K., Tomter, G., Golebiowska, E., Randen, I., Hauge, R., Aune, B., Oian, P., Dahl, L. B., Pirhonen, J., Lindeman, R., Husby, H., Haugen, G., Gronn, M., Skogen, B., Husebekk, A. (2007). A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood 110: 833-839 [Abstract] [Full Text]  
• Crowther, M. A., Abshire, T. C. (2007). Hemostasis and thrombosis. ASH-SAP 2007: 361-407 [Full Text]  
• Smellie, W S A, Forth, J, Bareford, D, Twomey, P, Galloway, M J, Logan, E C M, Smart, S R S, Reynolds, T M, Waine, C (2006). Best practice in primary care pathology: review 3.. J. Clin. Pathol. 59: 781-789 [Abstract] [Full Text]  
• Cines, D. B., Bussel, J. B. (2005). How I treat idiopathic thrombocytopenic purpura (ITP). Blood 106: 2244-2251 [Full Text]  
• Tsao, P.-N., Wei, S.-C., Su, Y.-N., Chou, H.-C., Chen, C.-Y., Hsieh, W.-S. (2005). Excess Soluble fms-Like Tyrosine Kinase 1 and Low Platelet Counts in Premature Neonates of Preeclamptic Mothers. Pediatrics 116: 468-472 [Abstract] [Full Text]  
• Stasi, R., Provan, D. (2004). Management of Immune Thrombocytopenic Purpura in Adults. Mayo Clin Proc. 79: 504-522 [Abstract]  
• Roberts, I, Murray, N A (2003). Neonatal thrombocytopenia: causes and management. Arch. Dis. Child. Fetal Neonatal Ed. 88: F359-F364 [Abstract] [Full Text]  
• Rayment, R, Birchall, J, Yarranton, H, Hewertson, J, Allen, D, Murphy, M F, Roberts, D J (2003). Neonatal alloimmune thrombocytopenia. BMJ 327: 331-332 [Full Text]  
• Hildebrandt, T, Powell, T (2002). Repeated antenatal intracranial haemorrhage: magnetic resonance imaging in a fetus with alloimmune thrombocytopenia. Arch. Dis. Child. Fetal Neonatal Ed. 87: F222-223 [Abstract] [Full Text]  
• Davoren, A, McParland, P, Barnes, C A, Murphy, W G (2002). Neonatal alloimmune thrombocytopenia in the Irish population: a discrepancy between observed and expected cases. J. Clin. Pathol. 55: 289-292 [Abstract] [Full Text]  
• Cines, D. B., Blanchette, V. S. (2002). Immune Thrombocytopenic Purpura. NEJM 346: 995-1008 [Full Text]  
• Burt, R. K., Slavin, S., Burns, W. H., Marmont, A. M. (2002). Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?. Blood 99: 768-784 [Abstract] [Full Text]  
• McCrae, K. R., Bussel, J. B., Mannucci, P. M., Remuzzi, G., Cines, D. B. (2001). Platelets: An Update on Diagnosis and Management of Thrombocytopenic Disorders. ASH Education Book 2001: 282-305 [Abstract] [Full Text]  
• OUWEHAND, W H, SMITH, G, RANASINGHE, E (2000). Management of severe alloimmune thrombocytopenia in the newborn. Arch. Dis. Child. Fetal Neonatal Ed. 82: 173F-175 [Full Text]  
• Bussel, J. B., Kunicki, T. J., Michelson, A. D. (2000). Platelets: New Understanding of Platelet Glycoproteins and Their Role in Disease. ASH Education Book 2000: 222-240 [Abstract] [Full Text]  
• Ajzenberg, N., Dreyfus, M., Kaplan, C., Yvart, J., Weill, B., Tchernia, G. (1998). Pregnancy-Associated Thrombocytopenia Revisited: Assessment and Follow-Up of 50 Cases. Blood 92: 4573-4580 [Abstract] [Full Text]  
• Williamson, L. M., Hackett, G., Rennie, J., Palmer, C. R., Maciver, C., Hadfield, R., Hughes, D., Jobson, S., Ouwehand, W. H. (1998). The Natural History of Fetomaternal Alloimmunization to the Platelet-Specific Antigen HPA-1a (PlA1, Zwa) as Determined by Antenatal Screening. Blood 92: 2280-2287 [Abstract] [Full Text]  
• Dreyfus, M., Kaplan, C., Verdy, E., Schlegel, N., Durand-Zaleski, I., Tchernia, G., the Immune Thrombocytopenia Working Group, (1997). Frequency of Immune Thrombocytopenia in Newborns: A Prospective Study. Blood 89: 4402-4406 [Abstract] [Full Text]  
• George, J. N., El-Harake, M. A., Raskob, G. E. (1994). Chronic Idiopathic Thrombocytopenic Purpura. NEJM 331: 1207-1211 [Full Text]  
• Bowman, M. A., Schwenk, T. L. (1994). Family Medicine. JAMA 271: 1670-1671 [Abstract]  
• Fischer, J., Dietl, J., Goelz, R., Burrows, R. F., Kelton, J. G. (1994). Fetal and Maternal Thrombocytopenia. NEJM 330: 940-941 [Full Text]